You are here: Industry Insights > immunotherapy

News List

MSD’s Keytruda Approved for Marketing in China in 164 Days, China to Speed Up to Enter the New Era of Immunotherapy 1°C
August 08, 2018
The State Drug Administration of China (SDA) updated the marketing application status of MSD’s Keytruda (pembrolizumab) on July 25, 2018 to “Approval completed-to be issued certificate”.
CR UK tests Asterias’ novel lung cancer immunotherapy jab pharmatimes
July 10, 2018
Cancer Research UK has begun testing a novel immunotherapy vaccine for lung cancer in Phase I trials, under a collaboration agreement with Asterias Biotherapeutics.
Christoph Westphal back on the horse with new immunotherapy startup fiercebiotech
May 04, 2018
Christoph Westphal is at it again. Not quite a year after stepping down from his CEO role at Flex Pharma, the serial biotech entrepreneur launched another Boston area-based company: T-Scan Therapeutics.
Simultaneous chemo and immunotherapy is effective in metastatic bladder cancer europeanpharmaceuticalreview
April 13, 2018
Researchers have discovered that giving metastatic bladder cancer patients simultaneous chemotherapy and immunotherapy is safe and that patients whose tumours have certain genetic mutations…
New immunotherapy for lung cancer shows promise of success worldpharmanews
April 11, 2018
In a groundbreaking development, results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination is surprisingly effective at controlling the disease's progression
Europe's biggest private biotech company raises $270 million en-cphi.cn
February 06, 2018
BioNTech has raised $270 million to support its work in developing personalized immunotherapies for cancer, ahead of an expected eventual stock market flotation.
Researchers develop a remote-controlled cancer immunotherapy system worldpharmanews
January 16, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.
Beckman Coulter Diagnostics Receives FDA Clearance for Automated Access AMH Immunoassay americanpharmaceuticalreview
December 28, 2017
Beckman Coulter Diagnostics Announces Automated Access AMH Immunoassay Used by the U.S. Food and Drug Administration (FDA) Through Its US In-vitro Diagnostics (IVD)
3 Immuno-oncology therapeutics expected to Blast Off in 2018 biospace
December 25, 2017
Immuno-oncology therapeutics have revolutionized certain types of cancer treatments.
Using light-emitting nanoparticles may lead to earlier detection of cancer europeanpharmaceuticalreview
December 13, 2017
Light-emitting nanoprobes can detect cancer early and track the spread of tiny tumours…

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page